Patenting of recombinant proteins: An analysis of tissue plasminogen activator (t-PA) in Europe, The United States and Japan
- 31 July 1995
- journal article
- Published by Elsevier in Research Policy
- Vol. 24 (4) , 645-663
- https://doi.org/10.1016/s0048-7333(98)80001-2
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Japan Cools Biotech SpendingNature Biotechnology, 1992
- Genentech wins in JapanNature, 1991
- Japanese Joint Ventures Come of AgeBio/Technology, 1991
- What The U.S. Biopharmaceutical Industry WantsNature Biotechnology, 1991
- Biotechnology in Japan — towards the year 2000 … and beyondTrends in Biotechnology, 1991
- The United States, Japan and the changing technological balanceResearch Policy, 1990
- Genentech wins round twoNature, 1990
- Claims on tissue plasminogen activatorNature, 1989
- Problems with anti-clotting drugNature, 1988
- Problems over TPA patent for Genentech in JapanNature, 1988